Recent reports have sparked significant concern regarding Wockhardt’s cough medication, specifically concerning the identification of unacceptable levels of dextromethorphan and certain contaminants. Although the company initially asserted its dedication to standards, various occurrences of unwanted outcomes, including severe brain injury and pot